Results 141 to 150 of about 42,305 (336)

Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aim Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Carlos Ferreira, Paula Soeiro, Sara Fonseca, Zaruhi Arakelyan, João Silva, Carlos Martins Silva, Francisco Cruz, Joana Guimarães, Tiago Antunes Lopes   +8 more
wiley   +1 more source

Botulinum Toxin Type A for Preventing Facial Trauma and Hypertrophic Scars: A Meta-Analysis and Trial Sequential Analysis. [PDF]

J Cosmet Dermatol
ABSTRACT Objective To evaluate the effectiveness and safety of local injection of botulinum toxin type A in preventing hypertrophic scars after facial trauma and surgery using meta‐analysis and sequential experimental analysis methods. Method Computer retrieval of randomized controlled trials on the prevention of facial scars with botulinum toxin type ...
Lu J, Chen Y, Xie H, Wang Y.
europepmc   +2 more sources

Phenotyping Overactive Bladder – Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele, Michael Samarinas, Apostolos Apostolidis, D. Carolina Ochoa, Giovanni Mosiello, Brigitte Schurch, Pradeep Tyagi, Alan Wein, Paul Abrams, John E. Speich   +9 more
wiley   +1 more source

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins. [PDF]

Toxins (Basel), 2020
Hassell TJW, Charles D.
europepmc   +1 more source

New Scientific and Technological Developments of Relevance to the Fifth Review Conference [PDF]

, 2001
Ye
Pearson, Graham S.
core  

Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives

, 2020
Mahesh R. Nepal, Tae Cheon Jeong
openalex   +2 more sources

BOTULINUM TOXIN [PDF]

Australian and New Zealand Journal of Ophthalmology, 1988
openaire   +2 more sources

Drinking Tremor

Movement Disorders Clinical Practice, EarlyView.
Victor Rebelo Procaci, Lyamara Apostólico de Azevedo, Orlando Graziani Povoas Barsottini, Henrique Ballalai Ferraz, José Luiz Pedroso   +4 more
wiley   +1 more source

Low‐value interventions to deimplement: A secondary analysis of a systematic review of low back pain clinical practice guidelines

PM&R, EarlyView.
Abstract Objective To perform a secondary review of low back pain (LBP) clinical practice guidelines (CPG) identified in a recently conducted systematic review and to synthesize and summarize low‐value recommendations as practices that may be candidates for deimplementation.
Daniel Tai, Eunyeop Kim, Prateek Grover, Alejandro Rodriguez, Timothy J. Olivier, Thiru M. Annaswamy   +5 more
wiley   +1 more source

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. [PDF]

Toxins (Basel), 2020
Spiegel LL, Ostrem JL, Bledsoe IO.
europepmc   +1 more source